Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey
Palliative Medicine January 22, 2024 Louis Plourde, Sue-Ling Chang, Houman Farzin et al. 22 citations
A survey of 2,800 adults in four Canadian provinces found high social acceptability of psilocybin-assisted therapy for existential distress at the end of life. 79.3% considered it a reasonable medical choice, 84.8% agreed public health insurance should cover it, and 63.3% would support legalization for medical purposes. More favorable attitudes were linked to prior psilocybin use, exposure to palliative care, and progressive political orientation. The findings suggest public support is strong enough to help mobilize resources and improve access to this emerging therapy in palliative and end-of-life care.